Essential Considerations for Radiologists in Diagnosing Hidradenitis Suppurativa.

Radiographics

From the Department of Radiology, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil (C.A.d.A., F.M.C.); Department of Radiology, Centro Universitário de Valença, Valença, Brazil (C.A.d.A.); Diagnósticos da América S/A, Rio de Janeiro, Brazil (C.A.d.A., P.H., F.M.C., J.P., P.A.M., H.W., C.C.M.D.C.); Department of Dermatology, Hospital Universitário Pedro Ernesto da Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil (M.L.); Department of Dermatology, Universidade Federal Fluminense, Niteroi, Brazil (F.B.L.); Bio Design Laboratory, Pontifícia Universidade Católica, Rio de Janeiro, Brazil (G.R., H.W., C.C.M.D.C.); Department of Radiology, Universidade Federal Fluminense, Niteroi, Brazil (C.C.M.D.C.); Department of Radiology, University Hospital Clementino Fraga Filho, R. Prof. Rodolpho Paulo Rocco, 255- Cidade Universitária, Rio de Janeiro, RJ 21941-617, Brazil (C.A.d.A.).

Published: November 2024

AI Article Synopsis

  • * Diagnosis is based on recognizing specific characteristics of the lesions and the chronic nature of the disease, without the need for definitive biological tests or biopsies.
  • * Treatment options depend on the disease's severity and can involve antibiotics, hormonal therapies, and surgery, with imaging techniques like high-frequency ultrasound being essential for accurate assessment and monitoring of the condition.

Article Abstract

Hidradenitis suppurativa, also referred to as , manifests as a persistent inflammatory skin disorder characterized by lesions such as deep nodules, abscesses, sinus tracts, and fibrotic scars. These manifestations predominantly occur in skin folds and intertriginous areas, notably in the axillary, inguinal, perianal, perineal, and inframammary regions. Due to similarities with other conditions in its initial stages, accurate diagnosis of hidradenitis suppurativa is often delayed, sometimes spanning several years. Diagnosis relies on identifying specific morphologic features (such as deep, inflamed, and painful nodules; sinus tracts; and scars), considering the affected sites (skin folds and areas with apocrine glands), and recognizing the chronic nature of the condition (persistent course with periods of exacerbation and remission). There are no definitive biologic or pathologic diagnostic tests, and biopsy of the affected area is not necessary. Treatment varies based on severity and may include topical and systemic antibiotics, hormonal therapy, immunomodulators, and surgery. Due to associated pain, increased site sensitivity, secretion drainage, odor, and scarring, this condition can have a negative psychosocial impact. Imaging studies, including high-frequency US and MRI with subsequent three-dimensional reconstruction, serve as valuable tools for precise staging, monitoring disease activity, and preoperative assessment. Currently, high-frequency US stands as the preferred method, incorporating sonographic classifications, while MRI and thee-dimensional imaging represent an emerging and promising approach. Imaging helps identify the extent of sinus tracts, assess involvement dimensions in advanced disease stages, and monitor proposed treatments. RSNA, 2024 Supplemental material and the slide presentation from the RSNA Annual Meeting are available for this article.

Download full-text PDF

Source
http://dx.doi.org/10.1148/rg.240066DOI Listing

Publication Analysis

Top Keywords

hidradenitis suppurativa
12
sinus tracts
12
skin folds
8
essential considerations
4
considerations radiologists
4
radiologists diagnosing
4
diagnosing hidradenitis
4
suppurativa hidradenitis
4
suppurativa referred
4
referred manifests
4

Similar Publications

Introduction: Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease affecting hair follicles, causing recurrent abscesses and nodules in intertriginous regions. The International HS Severity Score System (IHS4) is widely used to assess HS severity by counting inflammatory nodules, abscesses, and draining fistulas/tunnels. However, traditional clinical examinations may underestimate HS severity due to the presence of subclinical lesions.

View Article and Find Full Text PDF

Background: Therapeutic options for mild hidradenitis suppurativa (HS) represent a significant gap in the current treatment landscape, with no FDA approved therapies for early stage HS. Topical JAnus Kinase inhibitors (JAKi) are a compelling option due to the known upregulation of inflammatory JAK signaling in HS lesions and the recent success of systemic JAKi for moderate to severe HS.

Objectives: This is a pilot, single-site, open-label, prospective 24-week clinical trial with topical ruxolitinib (NCT04414514).

View Article and Find Full Text PDF

Introduction: Hidradenitis suppurativa (HS) is a chronic skin disease marked by recurrent abscesses, sinus tracts, and scarring, often accompanied by systemic symptoms. Diagnosed clinically, HS affects around 0.4% of people in western populations, but standardized treatment options are limited, leading to inconsistent outcomes.

View Article and Find Full Text PDF

Previous research has highlighted a significant association between inflammatory proteins and the development and progression of hidradenitis suppurativa (HS). Nevertheless, the potential causative link between these factors remains to be definitively established. To investigate the genetic correlation between inflammatory proteins and HS, linkage disequilibrium score regression (LDSC) was employed.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!